# Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/use-of-glucagon-like-peptide-1-receptor-agonists-and-risk-of-fracture-as/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johanna H. M. Driessen,Hein A. W. van Onzenoort,Jakob Starup‐Linde,Ronald M.A. Henry,Andrea M. Burden,Cees Neef,Joop P. van den Bergh,Peter Vestergaard,Frank de Vries |
| Citations | 74 |
| DOI | 10.1007/s00223-015-0037-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00223-015-0037-y.pdf |
| OpenAlex ID | https://openalex.org/W1951484771 |
| PMID | 26184119 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Johanna H. M. Driessen](https://scholariq.org/researchers/johanna-h-m-driessen/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.